+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dialyzer Market by Type and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4828925
  • Report
  • March 2019
  • Region: Global
  • 192 Pages
  • Allied Analytics LLP
The global dialyzer market was valued at $2,810 million in 2017 and is estimated to reach $4,529 million by 2025, registering a CAGR of 6.2 % from 2018 to 2025.



Dialyzers, also known as artificial kidneys, used during hemodialysis are fortified with a wide variety of membranes and within both the cellulosic and synthetic classes. Dialyzers are bifurcated into high-flux dialyzers and low-flux dialyzers. Among these, high-flux dialyzers are preferred while performing hemodialysis, as they are efficient and help remove larger molecules while performing dialysis as compared to the low-flux dialyzer.

The considerable rise in the geriatric population and increase in incidence of renal diseases, especially end stage renal disease (ESRD) are the key factors that contribute toward the growth of the global dialyzer market. Further, increase in funding for improved dialysis products and services, surge in incidence of chronic diseases such as diabetes and hypertension, and shortage of kidneys for transplantation are expected to propel the market growth. Although the dialyzer market continues to grow, certain factors hamper the growth of this market. The high cost procedure of hemodialysis and associated complications such as severe anemia and fluid overload is anticipated to hamper the market growth. On the contrary, technological advancements leading to better adoption and opportunities in emerging economies are anticipated to offer growth opportunities for the global dialyzer market.

The dialyzer market is segmented based on type and region. Based on type, the market is divided into high-flux dialyzer and low-flux dialyzer. Based on end user, the market is bifurcated into in-center dialyzer and home dialyzer. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global dialyzer market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided.
  • A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
  • An extensive analysis of the key segments of the industry helps understand the global trends in the dialyzer market.
  • Key players and their strategies are provided to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Type
  • High-Flux Dialyzer
  • Low-Flux Dialyzer

By End User
  • In -Center Dialyzer
  • Home Dialyzer

By Region
o North America
  • U.S.
  • Canada
  • Mexico
o Europe
  • UK
  • France
  • Germany
  • Italy
  • France
  • Austria
  • Russia
  • Rest of Europe
o Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Malaysia
  • Indonesia
  • Taiwan
  • Rest of Asia-Pacific
o LAMEA
  • Saudi Arabia
  • South Africa
  • Brazil
  • Turkey
  • Rest of LAMEA

KEY MARKET PLAYERS
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Browndove Healthcare (P) Ltd
  • Bain Medical Equipment
  • Fresenius Medical Care AG & Co. KGaA
  • Kawasumi Laboratories Inc.
  • Nikkiso Co., LTD.
  • Medtronic Plc. (Bellco),
  • Jihua Medical Apparatus & Instruments Co., Ltd
  • Allmed Medical Care Holdings Limited
  • Weigao Group
  • Farmasol
  • China Chengdu Wesley Biotech Co., Ltd
  • Toray Industries, Inc.
  • Medica Group
  • JMS Co. Ltd
  • Jiangsu Lengthen Life Science and Technology Co., Ltd
  • Medivators, Inc.
  • Dialifegroup
Frequently Asked Questions about the Global Dialyzer Market

What is the estimated value of the Global Dialyzer Market?

The Global Dialyzer Market was estimated to be valued at $2810.0 million in 2017.

What is the growth rate of the Global Dialyzer Market?

The growth rate of the Global Dialyzer Market is 6.1%, with an estimated value of $4529.0 million by 2025.

What is the forecasted size of the Global Dialyzer Market?

The Global Dialyzer Market is estimated to be worth $4529.0 million by 2025.
Note: Product cover images may vary from those shown

Chapter 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market share analysis, 2017
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Significant surge in the number of ESRD patients
3.5.1.2. Rise in incidence of diabetes and hypertension
3.5.1.3. Shortage of kidneys for transplantation
3.5.2. Restraints
3.5.2.1. Risks and complications associated with dialyzers reuse
3.5.2.2. High cost associated with the hemodialysis
3.5.3. Opportunities
3.5.3.1. Technological advancements leading to better adoption
3.6. Patent Analysis (2016-2018)
3.6.1. Patent analysis, by year
3.7. Clinical Trials for Dialyzers
Chapter 4: DIALYZER MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. High-flux dialyzer
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Low-Flux Dialyzer
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
Chapter 5: DIALYZER MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. In-Center Dialysis
5.2.1. Market analysis, by country
5.3. Home Dialysis
5.3.1. Market analysis, by country
Chapter 6: DIALYZER MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S. dialyzer market, by type
6.2.2.2. U.S. dialyzer market, by end user
6.2.2.3. Canada dialyzer market, by type
6.2.2.4. Canada dialyzer market, by end user
6.2.2.5. Mexico dialyzer market, by type
6.2.2.6. Mexico dialyzer market, by end user
6.2.3. North America dialyzer market, by type
6.2.4. North America dialyzer market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany dialyzer market, by type
6.3.2.2. Germany dialyzer market, by end user
6.3.2.3. France dialyzer market, by type
6.3.2.4. France dialyzer market, by end user
6.3.2.5. UK dialyzer market, by type
6.3.2.6. UK dialyzer market, by end user
6.3.2.7. Italy dialyzer market, by type
6.3.2.8. Italy dialyzer market, by end user
6.3.2.9. Spain dialyzer market, by type
6.3.2.10. Spain dialyzer market, by end user
6.3.2.11. Russia dialyzer market, by type
6.3.2.12. Russia dialyzer market, by end user
6.3.2.13. Austria dialyzer market, by type
6.3.2.14. Austria dialyzer market, by end user
6.3.2.15. Rest of Europe dialyzer market, by type
6.3.2.16. Rest of Europe dialyzer market, by end user
6.3.3. Europe dialyzer market, by type
6.3.4. Europe dialyzer market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan dialyzer market, by type
6.4.2.2. Japan dialyzer market, by end user
6.4.2.3. China dialyzer market, by type
6.4.2.4. China dialyzer market, by end user
6.4.2.5. India dialyzer market, by type
6.4.2.6. India dialyzer market, by end user
6.4.2.7. Australia dialyzer market, by type
6.4.2.8. Australia dialyzer market, by end user
6.4.2.9. South Korea dialyzer market, by type
6.4.2.10. South Korea dialyzer market, by end user
6.4.2.11. Taiwan dialyzer market, by type
6.4.2.12. Taiwan dialyzer market, by end user
6.4.2.13. Thailand dialyzer market, by type
6.4.2.14. Thailand dialyzer market, by end user
6.4.2.15. Malaysia dialyzer market, by type
6.4.2.16. Malaysia dialyzer market, by end user
6.4.2.17. Indonesia dialyzer market, by type
6.4.2.18. Indonesia dialyzer market, by end user
6.4.2.19. Rest of Asia-Pacific dialyzer market, by type
6.4.2.20. Rest of Asia-Pacific dialyzer market, by end user
6.4.3. Asia-Pacific dialyzer market, by type
6.4.4. Asia-Pacific dialyzer market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil dialyzer market, by type
6.5.2.2. Brazil dialyzer market, by end user
6.5.2.3. Saudi Arabia dialyzer market, by type
6.5.2.4. Saudi Arabia dialyzer market, by end user
6.5.2.5. South Africa dialyzer market, by type
6.5.2.6. South Africa dialyzer market, by end user
6.5.2.7. Turkey dialyzer market, by type
6.5.2.8. Turkey dialyzer market, by end user
6.5.2.9. Rest of LAMEA dialyzer market, by type
6.5.2.10. Rest of LAMEA dialyzer market, by end user
6.5.3. LAMEA dialyzer market, by type
6.5.4. LAMEA dialyzer market, by end user
Chapter 7: COMPANY PROFILES
7.1. ASAHI KASEI CORPORATION
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. BAXTER INTERNATIONAL INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. BROWNDOVE HEALTHCARE (P) LTD.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. BAIN MEDICAL EQUIPMENT
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Product Portfolio
7.6. FRESENIUS MEDICAL CARE AG & CO. KGAA
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product Portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. KAWASUMI LABORATORIES INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segment
7.7.4. Product Portfolio
7.7.5. Business performance
7.8. MEDTRONIC PLC. (BELCO)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. NIKKISO CO., LTD.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. JIHUA MEDICAL APPARATUS & INSTRUMENTS CO., LTD
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.11. ALLMED MEDICAL CARE HOLDINGS LIMITED
7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Product Portfolio
7.12. WEIGAO GROUP
7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Product Portfolio
7.12.5. Business performance
7.13. FARMASOL
7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Operating business segments
7.13.4. Product Portfolio
7.14. CHINA CHENGDU WESLEY BIOTECH CO., LTD
7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Operating business segments
7.14.4. Product Portfolio
7.15. TORAY INDUSTRIES, INC.
7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Operating business segments
7.15.4. Product Portfolio
7.15.5. Business performance
7.16. MEDICA GROUP
7.16.1. Company overview
7.16.2. Company snapshot
7.16.3. Operating business segments
7.16.4. Product Portfolio
7.17. JMS CO. LTD.
7.17.1. Company overview
7.17.2. Company snapshot
7.17.3. Operating business segments
7.17.4. Product Portfolio
7.17.5. Business performance
7.18. JIANGSU LENGTHEN LIFE SCIENCE AND TECHNOLOGY CO., LTD
7.18.1. Company overview
7.18.2. Company snapshot
7.18.3. Operating business segments
7.18.4. Product Portfolio
7.19. MEDIVATORS, INC.
7.19.1. Company overview
7.19.2. Company snapshot
7.19.3. Operating business segments
7.19.4. Product Portfolio
7.20. DIALIFEGROUP.COM
7.20.1. Company overview
7.20.2. Company snapshot
7.20.3. Operating business segments
7.20.4. Product Portfolio
Note: Product cover images may vary from those shown
According to this report titled, 'Dialyzer Market by Type and by End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,' the global dialyzer market was valued at $2810 million in 2017 and is projected to reach $4,529 million by 2025, growing at a CAGR of 6.2 % from 2018 to 2025. North America was the highest revenue contributor in 2017 and is expected to remain the same throughout the forecast period.

The function of the kidneys is to remove waste products and excess fluid from the blood. The process is carried out with the help of dialyzer (hemodialysis) when the kidneys do not function normally. Thereby, a dialyzer is also known as artificial kidney. Waste products, such as urea and creatinine are removed from the blood with the help of artificial and natural semipermeable membranes.

Increase in the number of ESRD patients, rise in incidence of diabetes and hypertension, and surge in funding for improved dialysis products and services drive the growth of the dialyzer market. Moreover, owing to lack of matching donors, dialysis is preferred over kidney transplant, which is expected to further fuel market growth. However, risks and complications associated with dialysis, and product recall are expected to hamper market growth.

Based on type, the high-flux dialyzer segment was the highest contributor toward market growth in 2017 and is expected to maintain its dominance during the forecast period. This is attributed to the fact that more permeable membrane of a high-flux dialyzer allows much faster removal of fluid and is thereby more preferably used as for hemodialysis.

Key Findings of the Dialyzer Market:

Based on type, the high-flux dialyzer segment accounted for nearly half share of the dialyzer industry in 2017.
The home dialyzer segment is anticipated to grow with the highest CAGR throughout the forecast period.
Based on region, North America accounted for a major share of the global dialyzer market in 2017.
Asia-Pacific is anticipated to grow at the highest rate in the dialyzer market during the analysis period, followed by LAMEA.

North America was the leading revenue contributor to the global market in 2017, owing to highly advanced healthcare infrastructure and new product launches by the key players. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, owing to the increase in awareness among healthcare professional regarding use of home dialyzer for the treatment of kidney failure related diseases.

The report provides a comprehensive analysis of the leading companies operating in the global market such as Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Browndove Healthcare (P) Ltd., Bain Medical Equipment, Fresenius Medical Care AG & Co. KGaA, Kawasumi Laboratories Inc., NIKKISO CO., LTD., Medtronic Plc. (Bellco), Jihua Medical Apparatus & Instruments Co., Ltd., Allmed Medical Care Holdings Limited, Weigao group, Farmasol, China Chengdu Wesley Biotech Co., Ltd., Toray Industries, Inc., Medica Group, JMS Co. Ltd., Jiangsu Lengthen Life Science and Technology Co., Ltd., Medivators, Inc., and Dialifegroup
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...